国际肝胆胰疾病杂志:英文版2022,Vol.21Issue(5):P.450-454,5.DOI:10.1016/j.hbpd.2022.08.014
Novel cellular therapies for hepatobiliary malignancies
摘要
关键词
Cellular therapy/Chimeric antigen receptor T cell therapy/Receptor-engineered T cell/Hepatobiliary malignancy分类
医药卫生引用本文复制引用
Jing-Nan Xue,Yan-Yu Wang,Yun-Chao Wang,Nan Zhang,Long-Hao Zhang,Zheng-Hui Lu,Li-Jin Zhao,Hai-Tao Zhao..Novel cellular therapies for hepatobiliary malignancies[J].国际肝胆胰疾病杂志:英文版,2022,21(5):P.450-454,5.基金项目
supported by grants from the International Science and Technology Cooperation Projects(2016YFE0107100) (2016YFE0107100)
the Capital Special Research Project for Health Development(2014-2-4012) (2014-2-4012)
the Beijing Natural Science Foundation(L172055 and 7192158) (L172055 and 7192158)
the National Ten-thousand Talent Program ()
the Fundamental Research Funds for the Central Universities(3332018032) (3332018032)
the CAMS Innovation Fund for Medical Science(CIFMS)(2017-I2M-4-003 and 2018-I2M-3-001)。 (CIFMS)